Prostate cancer: open trials in Norway

• NCT06136624

  Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Akershus University Hospital, Loerenskog · St. Olavs hospital HF, Trondheim

  Registry updated 2026-11-05

• NCT06925737

  A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Sykehuset Innlandet HF, Brumunddal · Akershus University Hospital, Loerenskog · Oslo Universitetssykehus HF, Oslo · St. Olavs hospital HF, Trondheim

  Registry updated 2026-10-30

• NCT07262619

  EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

  Trial Treatment · Phase 1/2 · Eikon Therapeutics

  Oslo University, Oslo

  Registry updated 2026-10-30

• NCT06172478

  A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  Trial Treatment · Phase 2 · Daiichi Sankyo

  Akershus universitetssykehus, Lørenskog · Haukeland universitetssjukehus, Lørenskog · Oslo Universitetssykehus HF, Radiumhospitalet, Oslo

  Registry updated 2026-10-26

• NCT07422597

  Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prostate Cancer

  Trial Treatment · Norwegian University of Science and Technology

  Sykehuset Levanger, Levanger · Orkdal sjukehus, Orkanger · St Olavs Hospital, Trondheim

  Registry updated 2026-10-21

• NCT07344779

  A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice

  Research · Bayer

  Many Locations, Many Locations

  Registry updated 2026-10-19

• 2026-526519-12-00

  Pilot study on tumor absorbed dose dynamics and pre-treatment dosimetry with [177Lu]-PSMA-I&T in metastatic castration-resistant prostate cancer

  Trial Treatment · Phase 2 · Universitetssykehuset Nord-Norge HF

  Universitetssykehuset Nord-Norge HF, Tromsoe

  Registry updated 2026-10-13

• 2024-517854-91-00

  Impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy

  Trial Treatment · Phase 3 · Pirkanmaan hyvinvointialue

  Sykehuset Telemark HF, Skien · Sykehuset I Vestfold HF, Toensberg

  Registry updated 2026-10-08

• NCT06626022

  Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.

  Trial Treatment · Phase 3 · University of Alberta

  Vestfold Hospital Trust, Tønsberg

  Registry updated 2026-09-25

• NCT05448547

  Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer

  Trial Treatment · Phase 3 · Sven Löffeler

  Sunmøre Hospital Trust, Ålesund · Vestre Viken Hospital Trust, Drammen · Innlandet Hospital Trust, Hamar · Sørlandet Hospital Trust, Kristiansand · Akerhus University Hospital, Lørenskog · Oslo University Hospital, Oslo · Telemark Hospital Trust, Skien · Stavanger University Hospital, Stavanger · Vestfold Hospital Trust (Hospital of Vestfold), Tønsberg · University Hospital of Northern Norway, Tromsø · St Olavs Hospital, Trondheim

  Registry updated 2026-09-10

• NCT03151629

  International Registry for Men With Advanced Prostate Cancer (IRONMAN)

  Research · Prostate Cancer Clinical Trials Consortium

  Oslo University Hospital, Oslo

  Registry updated 2026-05-22

• NCT07266129

  Virtual Biopsy of Prostate Cancer Using PSMA PET and AI

  Research · University Hospital of North Norway

  Universitetssykehuset Nord Norge, Tromsø, Tromsø

  Registry updated 2025-12-05

• NCT04186585

  Recommended Dose Estimation of BP-C2

  Trial Treatment · Phase 1 · Meddoc

  Meddoc, Skjetten

  Registry updated 2025-05-09

• NCT03903835

  ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer

  Trial Treatment · Phase 3 · Karolinska Institutet

  Helse Moere Og Romsdal HF, Aalesund · Ostfold Hospital Trust, Fredrikstad · Sorlandet Sykehus HF, Kristiansand S · Akershus University Hospital, Lorenskog · Helse Stavanger HF, Stavanger · Universitetssykehuset Nord-Norge HF, Tromsoe

  Registry updated 2025-04-09

• NCT06398613

  Preoperative PSMA PET/CT As Triage for EPLND in Patients Scheduled for RALP (PrePSMA)

  Trial Treatment · Oslo University Hospital

  Oslo University Hospital, Oslo

  Registry updated 2024-12-31

• NCT04549688

  Active Surveillance Plus (AS+): High-intensity Focused Ultrasound (HIFU) in Patients With Localized Prostate Cancer

  Trial Treatment · The Hospital of Vestfold

  Vestfold Hospital Trust (Hospital of Vestfold), Tønsberg

  Registry updated 2023-09-22

• NCT02102477

  Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer

  Trial Treatment · Olof Akre

  Sørlandet hospital, Kristiansand · Oslo University Hospital, Department of radiation Therapy, Oslo · Oslo University Hospital, Department Urology, Oslo · University Hospital of North Norway, Tromsø · St Olavs Hospital, Trondheim

  Registry updated 2022-03-31

All Prostate cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error